Finance

Lists
Why is ATTO down 4.30%?
Dive Deeper
ATTO:NASDAQ
Attovia Therapeutics Inc
$15.13
-4.30%
(-0.68) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATTO...
Open
$16.00
High
$16.00
Low
$14.20
Mkt. cap
691.63M
Avg. vol.
339.05K
Volume
322.87K
52-wk high
$28.00
52-wk low
$12.98
EPS
-$1.64
No. of employees
44
Open
$16.00
High
$16.00
Low
$14.20
Mkt. cap
691.63M
Avg. vol.
339.05K
Volume
322.87K
52-wk high
$28.00
52-wk low
$12.98
EPS
-$1.64
No. of employees
44
News stories
From web sources and news partners
About Attovia Therapeutics Inc
CEO-
Employees44
Founded2022
HeadquartersSan Carlos, California, United States
SectorHealth Care
IndustryBiotechnology
Websiteattovia.com
Analyst ratings
Based on 4 analysts giving stock ratings to ATTO in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ATTO in the last 3 months.
Highest
Current $15.13
$45.00 (+197.42%)
Average
$41.00 (+170.98%)
Lowest
$34.00 (+124.72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yigal Nochomovitz
Citi
Buy
Maintained
$34.00
+124.7%
11/10/2026
Michael Ulz
Morgan Stanley
Buy
Reiterated
$40.00
+164.4%
11/10/2026
Brian Abrahams
RBC Capital
Buy
Maintained
$45.00
+197.4%
11/09/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
$45.00
+197.4%
09/05/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
$39.00
+157.8%
09/03/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
360.00K
-
450.00K
-
Cost of goods sold
12.32M
16.51M
18.70M
20.29M
Cost of revenue
12.32M
16.51M
18.70M
20.29M
Research and development expenses
-
239.00K
241.00K
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.64M
3.21M
3.31M
4.73M
Operating expense
3.64M
3.45M
3.55M
4.73M
Total operating expenses
15.96M
19.96M
22.25M
25.02M
Operating income
-15.60M
-19.96M
-21.80M
-25.02M
Other non operating income
-32.00K
-27.00K
-25.00K
-34.00K
EBT including unusual items
-13.78M
-18.66M
-20.69M
-22.27M
EBT excluding unusual items
-13.78M
-18.66M
-20.69M
-22.27M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-13.78M
-18.66M
-20.69M
-22.27M
Net profit margin
-3,827.50%
-
-4,597.11%
-
Earnings per share
-
-
-4.88
-
Interest and investment income
1.86M
1.33M
1.14M
2.79M
Interest expense
-
-
-
-
Net interest expenses
1.86M
1.33M
1.14M
2.79M
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.38M
-19.71M
-21.56M
-24.78M
Gain or loss from assets sale
1.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps